ST Calabash Brothers: Obtain Medicine Registration Certificate

ST Calabash Brothers Announcement: The company has recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for Metformin Engeletin Tablets and Inhalation Compound Ipratropium Bromide Solution. Among them, the accumulated research and development expenses for Metformin Engeletin Tablets have reached 11.6 million yuan, and the accumulated research and development expenses for Inhalation Compound Ipratropium Bromide Solution have reached 3.1696 million yuan.